On July 9, 2026, in Hanoi, Cuu Long Pharmaceutical Joint Stock Company (DCL) and Duoc Vuong Trading Joint Stock Company officially signed a Memorandum of Understanding (MoU) on Comprehensive Strategic Cooperation, marking a significant milestone in the partnership between the two companies. The signing ceremony was attended by Ms. Nguyen Thi Thu Huong, Chief Executive Officer of DCL; Mr. Vu Manh Thang, Chairman of the Board of Directors of Duoc Vuong; along with senior executives from both companies and distinguished guests.
The signing ceremony marked the beginning of a comprehensive partnership between DCL and Duoc Vuong, reflecting the shared commitment of both companies to leverage their respective strengths, build a sustainable long-term relationship, create greater value for customers and partners, and enhance the competitiveness of Vietnam’s pharmaceutical industry.
Overview of the signing ceremony between DCL and Duoc Vuong.
During the meeting, executives from both companies discussed their strategic development directions, exchanged perspectives on the opportunities and challenges facing the pharmaceutical market, and officially signed the Memorandum of Understanding. Under the agreement, the two companies will gradually implement various areas of cooperation by maximizing their respective capabilities, resources, and competitive advantages, with the shared goal of achieving sustainable, long-term, and mutually beneficial growth.
Speaking at the ceremony, Ms. Nguyen Thi Thu Huong, CEO of DCL, stated: “At DCL, we firmly believe that collaboration is the foundation for creating new value and driving sustainable growth. The signing of this Memorandum of Understanding with Duoc Vuong not only creates opportunities to leverage the strengths of both companies but also lays the groundwork for developing solutions that deliver tangible benefits to customers, partners, and the community. We believe this partnership will generate meaningful progress in the years ahead.”
Founded in 1976, DCL has remained one of the few Vietnamese-owned pharmaceutical companies committed to its core values: quality as the foundation, innovation as the driving force, and long-term partnership as a sustainable value. Over the past 50 years, DCL has continuously invested in advanced technologies, strengthened its manufacturing capabilities, expanded its product portfolio, and modernized its management systems to meet the increasingly demanding needs of the market. Guided by a sustainable development strategy, the company places product quality, innovation, and people at the center of everything it does.
Meanwhile, Duoc Vuong specializes in pharmaceutical distribution and market development, with an extensive partner network and proven expertise in bringing high-quality pharmaceutical products closer to consumers. The combination of DCL’s manufacturing strength and Duoc Vuong’s market development capabilities is expected to create strong synergies, improve operational effectiveness, and unlock new growth opportunities for both companies.
Representatives of DCL and Duoc Vuong celebrate the beginning of a comprehensive partnership dedicated to improving community health.
At the event, Mr. Vu Manh Thang, Chairman of Duoc Vuong, shared: “We are truly honored that DCL has chosen Duoc Vuong as its comprehensive strategic partner. At Duoc Vuong, we have always aspired to bring high-quality medicines made by Vietnamese manufacturers to the global market. I believe that through this strategic partnership, we can contribute to improving both the quality of life and the health of the Vietnamese people.”
The signing of the comprehensive cooperation agreement not only marks the beginning of a strategic partnership between DCL and Duoc Vuong but also demonstrates the commitment of both companies to work together, share resources, and pursue long-term development goals. Built on mutual trust and complementary strengths, DCL and Duoc Vuong look forward to creating new value, contributing to the advancement of Vietnam’s pharmaceutical industry, and improving the quality of healthcare for the community.
